Brian P. Slingsby

Publications by Year

Research Areas

Cannabis and Cannabinoid Research, Wnt/β-catenin signaling in development and cancer, Synthesis and Reactivity of Heterocycles, Neurotransmitter Receptor Influence on Behavior, Pharmacological Receptor Mechanisms and Effects

Most-Cited Works

• → 3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3)(2001)160 cited
• → Discovery of 2-[(2,4-Dichlorophenyl)amino]- N -[(tetrahydro- 2 H -pyran-4-yl)methyl]-4-(trifluoromethyl)- 5-pyrimidinecarboxamide, a Selective CB2 Receptor Agonist for the Treatment of Inflammatory Pain(2007)120 cited
• → 6-Aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)(2003)111 cited
• → 5-Aryl-pyrazolo[3,4-b]pyridazines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)(2003)107 cited
• → 6-Heteroaryl-pyrazolo[3,4-b]pyridines: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3)(2003)85 cited
• → Discovery and structure–activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor(2010)70 cited
• → Discovery of 1-[4-(3-Chlorophenylamino)-1-methyl-1H-pyrrolo[3,2-c]pyridin-7-yl]-1-morpholin-4-ylmethanone (GSK554418A), a Brain Penetrant 5-Azaindole CB₂Agonist for the Treatment of Chronic Pain(2009)53 cited
• → Synthesis and evaluation of 3-amino-6-aryl-pyridazines as selective CB2 agonists for the treatment of inflammatory pain(2009)44 cited
• → ATP-Citrate Lyase as a Target for Hypolipidemic Intervention. Design and Synthesis of 2-Substituted Butanedioic Acids as Novel, Potent Inhibitors of the Enzyme(1996)33 cited
• → Pyridine-3-carboxamides as novel CB2 agonists for analgesia(2008)23 cited